Opinion editor’s note: Strib Voices publishes a mix of commentary online and in print each day. To contribute, click here.
•••
The Drug Enforcement Administration (DEA) is a powerful law enforcement agency that falls under the U.S. Department of Justice’s oversight umbrella. As the nation grapples with an opioid drug abuse epidemic claiming about 82,000 overdose deaths annually, the DEA’s mission of battling drug trafficking and enforcing controlled substance laws is vital to the public’s health and safety.
Given that reality, Americans deserve to know if the man tapped by President-elect Donald Trump to lead the DOJ as the nation’s next attorney general is himself an illicit drug user.
That’s a key reason why Congress should make public the results of a lengthy U.S. House Committee on Ethics investigation of former Florida Congressman Matt Gaetz’s alleged drug use and other alleged misconduct as soon as possible. If Gaetz, R-Fla., is guilty of breaking drug laws, as he stands accused, how can he be trusted to enforce criminal statutes as the nation’s chief law enforcement officer?
Even among questionable choices Trump has made for his second-term Cabinet, Gaetz’s nomination stands out as especially disturbing. The drug-use allegations are just one type of misconduct under scrutiny.
“On and off since 2021, the secretive House Ethics Committee has investigated Gaetz over various allegations, including the claim that he had sex with an underage girl, used illicit drugs, accepted bribes, misused campaign funds and shared inappropriate images on the House floor,” according to a recent BBC report.
The committee’s findings had been expected imminently. That suddenly changed when Trump nominated Gaetz as attorney general and Gaetz abruptly resigned his House seat. That decision derailed the report’s release.